- Home
- BBOT vs FBIZ Comparison
BBOT vs FBIZ Comparison
Compare BBOT & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBOT | FBIZ |
|---|---|---|
| Founded | 2016 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.6M | 529.7M |
| IPO Year | 2024 | 2012 |
Fundamental Metrics
Financial Performance| Metric | BBOT | FBIZ |
|---|---|---|
| Price | $2.68 | $70.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | $24.55 | ★ $78.80 |
| AVG Volume (30 Days) | ★ 520.6K | 54.4K |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | ★ 99.93 | 14.23 |
| EPS | N/A | ★ 3.28 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.80 |
| Revenue Next Year | N/A | $7.57 |
| P/E Ratio | ★ N/A | $21.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.71 | $48.09 |
| 52 Week High | $14.87 | $73.74 |
Technical Indicators
Market Signals| Indicator | BBOT | FBIZ |
|---|---|---|
| Relative Strength Index (RSI) | 14.74 | 52.06 |
| Support Level | N/A | $69.91 |
| Resistance Level | $9.36 | $71.50 |
| Average True Range (ATR) | 0.23 | 1.46 |
| MACD | 0.08 | 0.08 |
| Stochastic Oscillator | 0.37 | 71.04 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.